Right ventricular dysfunction in the R6/2 transgenic mouse model of Huntington's disease is unmasked by dobutamine

Journal of Huntington's Disease

Volumn 3, Issue 1, 2014, Pages 25-32

  Buonincontri, Guido ^a   Wood, Nigel I ^a   Puttick, Simon G ^a   Ward, Alex O ^a   Carpenter, T Adrian ^a   Sawiak, Stephen J ^a,b   Morton, A Jennifer ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cognitive function; heart failure; Huntington's Disease; MRI; right ventricle

Indexed keywords

DOBUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DISEASE COURSE; EXERCISE TEST; FEMALE; HEART FUNCTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUNTINGTON CHOREA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

COGNITIVE FUNCTION; HEART FAILURE; HUNTINGTON'S DISEASE; MRI; RIGHT VENTRICLE;

ANIMALS; CARDIAC IMAGING TECHNIQUES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOBUTAMINE; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING, CINE; MICE; MICE, TRANSGENIC; STROKE VOLUME; SYMPATHOMIMETICS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84908109494     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-130083     Document Type: Article

References (50)

1. Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F, Wanker EE, Doherty P, Davies SW, Bates GP. Formation of polyglutamine inclusions in non-CNS tissue. Human Molecular Genetics. 1999;8:813-22. (Pubitemid 29189048)
2. Gilbert GJ. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 2009;73:572; author reply 572.
3. Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RAC. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 2008;71:1506-13.
4. Chiu E, Alexander L. Causes of death in Huntington's disease. The Medical Journal of Australia. 1982;1:153.
5. Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS. Conditions associated with Huntington's disease at death. A case-control study. Archives of Neurology. 1988;45:878-80.
6. Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS. Huntington's disease mortality in the United States. Neurology. 1988;38:769-9.
7. van der Burg JMM, Björkqvist M, Brundin P. Beyond the brain:Widespread pathology in Huntington's disease. Lancet Neurology. 2009;8:765-74.
8. Andrich J, Schmitz T, Saft C, Postert T, Kraus P, Epplen JT, Przuntek H, Agelink MW. Autonomic nervous system function in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2002;72:726-31. (Pubitemid 34557013)
9. Aziz NA, Anguelova GV,Marinus J, van Dijk JG, Roos RAC. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies. 2010;17:1068-74.
10. Bär KJ, Boettger MK, Andrich J, Epplen JT, Fischer F, Cordes J, Koschke M, Agelink MW. Cardiovagal modulation upon postural change is altered in Huntington's disease. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies. 2008;15:869-71.
11. Kobal J, Melik Z, Cankar K, Bajrovic FF, Meglic B, Peterlin B, Zaletel M. Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease. Acta Neurologica Scandinavica. 2010;121:392-9.
12. Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RA. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord. 2010;16:345-50.
13. Crook ZR, Housman D. Huntington's disease: Can mice lead the way to treatment? Neuron. 2011;69:423-35.
14. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2005;25:157-63. (Pubitemid 40110776)
15. Maywood ES, Fraenkel E, McAllister CJ, Wood N, Reddy AB, Hastings MH, Morton AJ. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2010;30:10199-204.
16. KudoT, Schroeder A, LohDH,Kuljis D, JordanMC,RoosKP, Colwell CS. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Experimental Neurology. 2011;228:80-90.
17. Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du X-J. Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. The Journal of Physiology. 2012;590:5845-60.
18. Pattison JS, Robbins J. Protein misfolding and cardiac disease: Establishing cause and effect. Autophagy. 2008;4:821-3.
19. Pattison JS, Sanbe A, Maloyan A, Osinska H, Klevitsky R, Robbins J. Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation. 2008;117:2743-51. (Pubitemid 351770455)
20. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiology of Disease. 2009;33:20-7.
21. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA. Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 2009;33:12-9.
22. Wood NI, Glynn D, Morton AJ. "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease. Neurobiology of Disease. 2011;42:427-37.
23. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Characterization of progressive motor deficits in mice transgenic for the human huntington's disease mutation. J Neurosci. 1999;19:3248-57. (Pubitemid 29174016)
24. Ciamei A, Morton AJ. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease. Neurobiology of Learning and Memory. 2008;89:533-44.
25. Ciamei A, Morton AJ. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease. Neurobiology of Learning and Memory. 2009;92:417-28.
26. Lione LA, Carter RJ, Hunt MJ, Bates GP,Morton AJ, Dunnett SB. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 1999;19:10428-37. (Pubitemid 30228050)
27. Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YLM, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW, Morton AJ, Morton J. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. PloS One. 2010;5:e9077.
28. Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR. Cardiac dysfunction in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 2007;25:297-308. (Pubitemid 46127844)
29. Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter TA, Giussani DA, Morton AJ. Direct Evidence of Progressive Cardiac Dysfunction in a Transgenic Mouse Model of Huntington's Disease - Journal of Huntington's Disease - Volume 1, Number 1 / 2012 - IOS Press. Journal of Huntington's Disease. 2012;1:65-72.
30. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883-91. (Pubitemid 44673364)
31. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493-506. (Pubitemid 26374323)
32. Duzdevich D, Li J, Whang J, Takahashi H, Takeyasu K, Dryden DTF, Morton AJ, Edwardson JM. Unusual structures are present in DNA fragments containing super-long Huntingtin CAG repeats. PloS One. 2011;6:e17119.
33. Carter RJ, Hunt MJ, Morton AJ. Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene. Movement Disorders: Official Journal of the Movement Disorder Society. 2000;15:925-37.
34. Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, Wight JM. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice. Neurobiol Dis. 2009;33:331-41.
35. Sawiak SJ,Wood NI,Williams GB, Morton AJ, CarpenterTA. Voxel-based morphometry with templates and validation in a mouse model of Huntington's disease. Magn Reson Imaging. 2013;31:1522-31.
36. Tyrankiewicz U, Skorka T, Jablonska M, Petkow-Dimitrow P, Chlopicki S. Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo. Journal of Magnetic Resonance Imaging: JMRI. 2013;37:669-77.
37. Wiesmann F, Frydrychowicz A, Rautenberg J, Illinger R, RommelE, Haase A, Neubauer S. Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. American Journal of Physiology Heart and Circulatory Physiology. 2002;283:H1065-71.
38. Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H. Design and validation of Segment-freely available software for cardiovascular image analysis. BMC Medical Imaging. 2010;10:1.
39. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717-31. (Pubitemid 351482595)
40. Wiesmann F, Ruff J, Engelhardt S, Hein L, Dienesch C, Leupold A, Illinger R, Frydrychowicz A, Hiller KH, Rommel E, Haase A, Lohse MJ, Neubauer S. Dobutamine-stress magnetic resonance microimaging in mice: Acute changes of cardiac geometry and function in normal and failing murine hearts. Circulation Research. 2001;88:563-9. (Pubitemid 32275791)
41. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiology of Disease. 2008;31:1-19.
42. Blain A, Greally E, Laval S, Blamire A, Straub V, Macgowan GA. Beta-blockers, left and right ventricular function, and invivo calcium influx in muscular dystrophy cardiomyopathy. PloS One. 2013;8:e57260.
43. Stuckey DJ, Carr CA, Camelliti P, Tyler DJ, Davies KE, Clarke K. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PloS One. 2012;7:e28569.
44. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 1991;352:536-9.
45. Harpole DH, Jones RH. Left ventricular function under stress before and after myocardial revascularization. American Heart Journal. 1992;124:273-9.
46. Goetschalckx K, Rademakers F, Bogaert J. Right ventricular function by MRI. Current Opinion in Cardiology. 2010;25:451-5.
47. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436-48. (Pubitemid 351501496)
48. Jones U, Enright S, Busse M, Rosser A. A Pilot Study on Respiratory Function in People with Huntington's Disease. Journal of Neurology Neurosurgery and Psychiatry. 2010;81:A42-3.
49. Buonincontri G, Methner C, Krieg T, Carpenter TA, Sawiak SJ. A fast protocol for infarct quantification in mice. Journal of Magnetic Resonance Imaging: JMRI. 2013.
50. van Rugge FP, van der Wall EE, de Roos A, Bruschke AV. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. Journal of the American College of Cardiology. 1993;22:431-9. (Pubitemid 23214555)